Zhixu He

748 total citations
36 papers, 446 citations indexed

About

Zhixu He is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Zhixu He has authored 36 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Epidemiology. Recurrent topics in Zhixu He's work include MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (6 papers) and Cell death mechanisms and regulation (3 papers). Zhixu He is often cited by papers focused on MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (6 papers) and Cell death mechanisms and regulation (3 papers). Zhixu He collaborates with scholars based in China, United States and Rwanda. Zhixu He's co-authors include Lin Xu, Xianyao Wang, Juanjuan Zhao, Omar Mukama, Muzammal Hussain, Xu Zhao, Lingwen Zeng, Zhijian Yi, Wei Li and Ting Yuan and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Biochemical Pharmacology and Experimental Cell Research.

In The Last Decade

Zhixu He

33 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhixu He China 11 286 85 68 38 34 36 446
Bowen Liu China 12 256 0.9× 47 0.6× 27 0.4× 39 1.0× 25 0.7× 27 514
Regina Weinmüllner Austria 7 186 0.7× 74 0.9× 40 0.6× 56 1.5× 75 2.2× 8 573
Ting Yao China 10 220 0.8× 36 0.4× 40 0.6× 63 1.7× 64 1.9× 24 638
Hongbo Xu China 12 272 1.0× 60 0.7× 34 0.5× 68 1.8× 97 2.9× 31 540
Juntong Li China 10 249 0.9× 55 0.6× 42 0.6× 57 1.5× 40 1.2× 24 468
Chen Tan China 11 196 0.7× 61 0.7× 30 0.4× 40 1.1× 65 1.9× 15 420
Ryan Dickerson United States 12 319 1.1× 59 0.7× 30 0.4× 39 1.0× 41 1.2× 15 668
Yumeng Shen China 13 349 1.2× 159 1.9× 61 0.9× 57 1.5× 70 2.1× 36 698
Sadat Dokaneheifard United States 10 247 0.9× 97 1.1× 27 0.4× 25 0.7× 43 1.3× 13 506

Countries citing papers authored by Zhixu He

Since Specialization
Citations

This map shows the geographic impact of Zhixu He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhixu He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhixu He more than expected).

Fields of papers citing papers by Zhixu He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhixu He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhixu He. The network helps show where Zhixu He may publish in the future.

Co-authorship network of co-authors of Zhixu He

This figure shows the co-authorship network connecting the top 25 collaborators of Zhixu He. A scholar is included among the top collaborators of Zhixu He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhixu He. Zhixu He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wu, Yan, Dan Zhang, Xiaofang Dai, et al.. (2024). Micropeptides: potential treatment strategies for cancer. Cancer Cell International. 24(1). 134–134. 13 indexed citations
3.
Zhang, Longze, et al.. (2024). Advancements in Research on Mesenchymal Stem-Cell-Derived Exosomal miRNAs: A Pivotal Insight into Aging and Age-Related Diseases. Biomolecules. 14(11). 1354–1354. 3 indexed citations
4.
Wang, Nuoxin, et al.. (2024). Small diameter vascular grafts: progress on electrospinning matrix/stem cell blending approach. Frontiers in Bioengineering and Biotechnology. 12. 1385032–1385032. 3 indexed citations
5.
Tian, Chuan, et al.. (2024). Mesenchymal stem cells reverse thymus aging by reprogramming the DNA methylation of thymic epithelial cells. Regenerative Therapy. 27. 126–169. 1 indexed citations
6.
Chen, Chao, Mengmeng Guo, Xu Zhao, et al.. (2023). MicroRNA-7: A New Intervention Target for Inflammation and Related Diseases. Biomolecules. 13(8). 1185–1185. 7 indexed citations
7.
Yi, Yang, et al.. (2023). Trilobatin rescues fulminant hepatic failure by targeting COX2: Involvement of ROS/TLR4/NLRP3 signaling. Phytomedicine. 120. 155059–155059. 15 indexed citations
8.
Zhao, Xu, Juanjuan Zhao, Dongmei Li, et al.. (2023). Akkermansia muciniphila: A potential target and pending issues for oncotherapy. Pharmacological Research. 196. 106916–106916. 29 indexed citations
9.
Yang, Han, Long‐Qing Chen, Juanjuan Zhao, et al.. (2023). MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges?. Biomolecules. 13(6). 877–877. 41 indexed citations
10.
Xu, Shangfu, Anling Hu, Taotao Liu, et al.. (2023). The role of calcium-sensing receptor in ginsenoside Rg1 promoting reendothelialization to inhibit intimal hyperplasia after balloon injury. Biomedicine & Pharmacotherapy. 163. 114843–114843. 1 indexed citations
11.
Wang, Jing, et al.. (2023). The progress in the relationship between trace elements and acute lymphoblastic leukemia. Frontiers in Cell and Developmental Biology. 11. 1145563–1145563. 2 indexed citations
12.
Li, Jiahuan, et al.. (2022). Carvedilol exhibits anti-acute T lymphoblastic leukemia effect in vitro and in vivo via inhibiting β-ARs signaling pathway. Biochemical and Biophysical Research Communications. 639. 150–160. 2 indexed citations
13.
Wang, Ya, Juanjuan Zhao, Shipeng Chen, et al.. (2022). Let-7 as a Promising Target in Aging and Aging-Related Diseases: A Promise or a Pledge. Biomolecules. 12(8). 1070–1070. 15 indexed citations
14.
Li, Xue, et al.. (2022). A Prognostic Model of Seven Immune Genes to Predict Overall Survival in Childhood Acute Myeloid Leukemia. BioMed Research International. 2022(1). 7724220–7724220. 5 indexed citations
15.
Xiao, Xiao, Ping Yi, Qing Rao, et al.. (2021). L20, a Calothrixin B analog, induces intrinsic apoptosis on HEL cells through ROS/γ-H2AX/p38 MAPK pathway. Biomedicine & Pharmacotherapy. 137. 111336–111336. 13 indexed citations
16.
Hu, Lin, Ya Zhou, Jing Yang, et al.. (2021). MicroRNA-7 overexpression positively regulates the CD8+ SP cell development via targeting PIK3R1. Experimental Cell Research. 407(2). 112824–112824. 8 indexed citations
17.
Mukama, Omar, Ting Yuan, Zhixu He, et al.. (2020). A high fidelity CRISPR/Cas12a based lateral flow biosensor for the detection of HPV16 and HPV18. Sensors and Actuators B Chemical. 316. 128119–128119. 102 indexed citations
18.
Mao, Ling, Ya Zhou, Long‐Qing Chen, et al.. (2020). Identification of atypical mitogen-activated protein kinase MAPK4 as a novel regulator in acute lung injury. Cell & Bioscience. 10(1). 121–121. 10 indexed citations
19.
Chen, Cang, Yang Li, Guo Ge, et al.. (2019). Non-toxic HSC Transplantation-Based Macrophage/Microglia-Mediated GDNF Delivery for Parkinson’s Disease. Molecular Therapy — Methods & Clinical Development. 17. 83–98. 23 indexed citations
20.
He, Zhixu, et al.. (2017). Subacute sclerosing panencephalitis should be eliminated by measles vaccination. Human Vaccines & Immunotherapeutics. 13(9). 2038–2040. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026